Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02219659 · ClinicalTrials.gov registry record · NA
Pilot Study on Pairing Sedation Strategies and Weaning
A NA study, sponsored by MemorialCare Health System.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT02219659 is a NA study that has completed, run by MemorialCare Health System. The registered enrollment target is 90 participants.
The verdict
NCT02219659, a NA study, has completed, sponsored by MemorialCare Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
A three-arm, randomized, pilot study, to assess the feasibility for the analgesia-first sedation (AFS) study arm/intervention (Fentanyl push first). The study will assess additional outcomes for all three (3) validated strategies for sedation and pain management.
Interventions
- DRUG Sedation Protocol with Daily Interruption
- DRUG Sedation Protocol Without Daily Interruption
- DRUG Fentanyl Push First
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2014-12 |
| Est. Completion | 2018-05-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02219659
The ClinicalTrials.gov registry entry for NCT02219659 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MemorialCare Health System, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Sedation Protocol with Daily Interruption is the first listed.
NCT02219659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02219659 about?
NCT02219659 is a clinical study titled "Pilot Study on Pairing Sedation Strategies and Weaning". A three-arm, randomized, pilot study, to assess the feasibility for the analgesia-first sedation (AFS) study arm/intervention (Fentanyl push first). The study will assess additional outcomes for all three (3) validated strategies for sedation and pain management.
What is the current status of trial NCT02219659?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2014-12. Estimated completion is 2018-05-18.
What interventions are being tested in trial NCT02219659?
The interventions under investigation include: Sedation Protocol with Daily Interruption (DRUG), Sedation Protocol Without Daily Interruption (DRUG), Fentanyl Push First (DRUG).
Who is sponsoring clinical trial NCT02219659?
This trial is sponsored by MemorialCare Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.